• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

AbCellera Biologics (ABCL)

Ordinary Shares
Sell: $5.40|Buy: $5.55|Change: 0.11 (-1.97%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Find out more

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to theclinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Address

1300 - 777 Dunsmuir Street
Pacific Centre
Vancouver
BC
CAN
V7Y 1K2

Telephone

+1 604 559-9005

Website

https://www.abcellera.com

Sector 

Healthcare

Forecast key dates

NameKey Date
AbCellera Biologics Inc Second Quarter Earnings Conference Call for 20262026-08-07T17:00:00
AbCellera Biologics Inc Second Quarter Earnings Results for 20262026-08-07T00:00:00
AbCellera Biologics Inc Annual General Meeting for 20262026-06-12T09:00:00
AbCellera Biologics Inc First Quarter Earnings Conference Call for 20262026-05-08T17:00:00
AbCellera Biologics Inc First Quarter Earnings Results for 20262026-05-08T00:00:00
AbCellera Biologics Inc Fourth Quarter Earnings Conference Call for 20252026-02-27T17:00:00
AbCellera Biologics Inc Fourth Quarter Earnings Results for 20252026-02-27T00:00:00
AbCellera Biologics Inc Annual Report for 20252026-02-27T00:00:00
Piper Sandler 37th Annual Healthcare Conference2025-12-02T00:00:00
Jefferies Global Healthcare Conference2025-11-18T00:00:00
AbCellera Biologics Inc Third Quarter Earnings Conference Call for 20252025-11-06T17:00:00
AbCellera Biologics Inc Third Quarter Earnings Result for 20252025-11-06T00:00:00

Previous key dates

NameKey Date
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-08T09:00:00
Wells Fargo Healthcare Conference2025-09-05T09:30:00
AbCellera Biologics Inc Second Quarter Earnings Conference Call for 20252025-08-07T17:00:00
AbCellera Biologics Inc Second Quarter Earnings Results for 20252025-08-07T00:00:00
AbCellera Biologics Inc Annual General Meeting for 20252025-06-12T09:00:00
AbCellera Biologics Inc First Quarter Earnings Conference Call for 20252025-05-08T17:00:00
AbCellera Biologics Inc First Quarter Earnings Result for 20252025-05-08T00:00:00
KeyBanc Capital Markets Healthcare Forum2025-03-19T13:30:00
45th Annual TD Cowen Health Care Conference2025-03-03T14:30:00
AbCellera Biologics Inc Fourth Quarter Earnings Conference Call for 20242025-02-27T17:00:00
AbCellera Biologics Inc Fourth Quarter Earnings Result for 20242025-02-27T00:00:00
AbCellera Biologics Inc Annual Report for 20242025-02-27T00:00:00
43rd Annual JP Morgan Healthcare Conference2025-01-15T16:30:00
Piper Sandler 36th Annual Healthcare Conference2024-12-03T11:30:00
Jefferies London Healthcare Conference2024-11-19T10:00:00
Stifel Healthcare Conference2024-11-18T08:30:00
Society for Immunotherapy of Cancer (SITC) Annual Meeting 20242024-11-08T09:00:00
AbCellera Biologics Inc Third Quarter Earnings Conference Call for 20242024-11-04T17:00:00
AbCellera Biologics Inc Third Quarter Earnings Result for 20242024-11-04T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.